DPP4 and type 2 diabetes mellitus: Although the researchers did not show an effect of the polymorphism, the other trials about dipeptidyl peptidase-4 (DPP-4) inhibitors and their mechanism of action suggest that the rs6923761 polymorphism might nevertheless influence the response to T2DM treatment, as shown in our study.